News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
782,671 Results
Type
Article (55487)
Company Profile (517)
Press Release (726653)
Multimedia
Podcasts (148)
Webinars (23)
Section
Business (217942)
Career Advice (2883)
Deals (37441)
Drug Delivery (143)
Drug Development (87299)
Employer Resources (185)
FDA (17459)
Job Trends (16033)
News (370349)
Policy (35815)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2942)
Academic (1)
Accelerated approval (40)
Adcomms (33)
Allergies (160)
Alliances (53409)
ALS (190)
Alzheimer's disease (1807)
Antibody-drug conjugate (ADC) (362)
Approvals (17667)
Artificial intelligence (604)
Autoimmune disease (179)
Automation (45)
Bankruptcy (391)
Best Places to Work (12288)
BIOSECURE Act (22)
Biosimilars (207)
Biotechnology (355)
Bladder cancer (172)
Brain cancer (65)
Breast cancer (686)
Cancer (5236)
Cardiovascular disease (456)
Career advice (2441)
Career pathing (42)
CAR-T (308)
CDC (62)
Celiac Disease (2)
Cell therapy (825)
Cervical cancer (38)
Clinical research (74196)
Collaboration (1913)
Company closure (4)
Compensation (1207)
Complete response letters (76)
COVID-19 (2946)
CRISPR (107)
C-suite (952)
Cystic fibrosis (153)
Data (6590)
Decentralized trials (2)
Denatured (46)
Depression (157)
Diabetes (539)
Diagnostics (7115)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (290)
Drug pricing (219)
Drug shortages (31)
Duchenne muscular dystrophy (257)
Earnings (93337)
Editorial (68)
Employer branding (23)
Employer resources (163)
Events (126428)
Executive appointments (1061)
FDA (20752)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1600)
Gene editing (227)
Generative AI (52)
Gene therapy (689)
GLP-1 (1114)
Government (5197)
Grass and pollen (8)
Guidances (387)
Healthcare (20269)
HIV (74)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (299)
Immuno-oncology (75)
Indications (128)
Infectious disease (3254)
Inflammatory bowel disease (215)
Inflation Reduction Act (17)
Influenza (132)
Intellectual property (267)
Interviews (559)
IPO (17263)
IRA (59)
Job creations (4110)
Job search strategy (1982)
JPM (70)
Kidney cancer (20)
Labor market (88)
Layoffs (630)
Leadership (43)
Legal (8790)
Liver cancer (100)
Longevity (18)
Lung cancer (708)
Lymphoma (393)
Machine learning (46)
Management (63)
Manufacturing (872)
MASH (181)
Medical device (14492)
Medtech (14554)
Mergers & acquisitions (21269)
Metabolic disorders (1423)
mRNA (195)
Multiple sclerosis (175)
NASH (23)
Neurodegenerative disease (373)
Neuropsychiatric disorders (106)
Neuroscience (3192)
Neurotech (1)
NextGen: Class of 2026 (7264)
Non-profit (4939)
Now hiring (69)
Obesity (687)
Opinion (330)
Ovarian cancer (172)
Pain (223)
Pancreatic cancer (249)
Parkinson's disease (313)
Partnered (35)
Patents (537)
Patient recruitment (542)
Peanut (64)
People (64219)
Pharmaceutical (88)
Pharmacy benefit managers (32)
Phase 1 (23147)
Phase 2 (32537)
Phase 3 (24250)
Pipeline (5920)
Policy (343)
Postmarket research (2933)
Preclinical (9945)
Press Release (70)
Prostate cancer (267)
Psychedelics (59)
Radiopharmaceuticals (311)
Rare diseases (981)
Real estate (6501)
Recruiting (77)
Regulatory (26714)
Reports (54)
Research institute (2665)
Resumes & cover letters (457)
Rett syndrome (30)
RNA editing (21)
RSV (86)
Schizophrenia (164)
Series A (269)
Series B (205)
Service/supplier (15)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (45)
Startups (3979)
State (2)
Stomach cancer (21)
Supply chain (113)
Tariffs (96)
The Weekly (100)
Vaccines (1141)
Venture capital (100)
Weight loss (464)
Women's health (102)
Worklife (22)
Date
Today (41)
Last 7 days (911)
Last 30 days (2954)
Last 365 days (31479)
2026 (5131)
2025 (31847)
2024 (37121)
2023 (41887)
2022 (53213)
2021 (57874)
2020 (56596)
2019 (49834)
2018 (37690)
2017 (34711)
2016 (34538)
2015 (40637)
2014 (34685)
2013 (29997)
2012 (32065)
2011 (32509)
2010 (30801)
Location
Africa (935)
Alabama (94)
Alaska (7)
Arizona (333)
Arkansas (15)
Asia (44341)
Australia (8022)
California (11965)
Canada (3424)
China (1198)
Colorado (502)
Connecticut (513)
Delaware (351)
Europe (99573)
Florida (1768)
Georgia (380)
Hawaii (3)
Idaho (65)
Illinois (948)
India (75)
Indiana (550)
Iowa (24)
Japan (456)
Kansas (133)
Kentucky (46)
Louisiana (28)
Maine (72)
Maryland (1469)
Massachusetts (8666)
Michigan (349)
Minnesota (664)
Mississippi (7)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (128)
New Hampshire (87)
New Jersey (3177)
New Mexico (32)
New York (3151)
North Carolina (1620)
North Dakota (9)
Northern California (5837)
Ohio (357)
Oklahoma (21)
Oregon (47)
Pennsylvania (2394)
Puerto Rico (25)
Rhode Island (52)
South America (1305)
South Carolina (69)
South Dakota (1)
Southern California (4650)
Tennessee (184)
Texas (1847)
United States (42645)
Utah (363)
Vermont (1)
Virginia (286)
Washington D.C. (87)
Washington State (984)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
782,671 Results for "cellectar biosciences formerly known as novelos therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellectar Biosciences Expands Global Intellectual Property Estate
February 17, 2026
·
4 min read
Press Releases
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
February 25, 2026
·
2 min read
Press Releases
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 17, 2025
·
4 min read
Press Releases
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
October 8, 2025
·
5 min read
Press Releases
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
January 9, 2026
·
6 min read
Press Releases
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 14, 2025
·
11 min read
Press Releases
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
October 15, 2025
·
6 min read
Press Releases
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
September 12, 2025
·
7 min read
Press Releases
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
November 7, 2025
·
2 min read
Press Releases
Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
October 1, 2025
·
8 min read
1 of 78,268
Next
